Saturday 17 October 2026 Export LGMK’s income statement to Excel — free account

LogicMark, Inc.

LGMK Healthcare Health Information Services

LogicMark, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 15.4% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS grew 35.4% and free cash flow grew 96.4%, each against the same quarter a year earlier.

1.30 0.10 +8.33%

Follow LGMK

Alert me

Market cap: $1.7M
P/E: 0.0×
Fwd P/E: −0.2×
Dividend yield: —
F-score: 5/9
Altman Z: −8.13
Beneish M: −2.77
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 1.74

Revenue 12.54

Net Income (6.23)

Free Cash Flow (5.45)

Net Debt (6.63)

Current Ratio 4.88

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (0.16)

P/S ratio 0.09

P/B ratio 0.09

Past 5Y EPS Growth —

This Y EPS Growth 81.39%

Next Y EPS Growth —

Next Y revenue growth 16.06%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/S against its own 10 years 18.41%

10-year low 10-year high

P/B against its own 10 years 22.15%

10-year low 10-year high

EV/FCF against its own 10 years 5.11%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	6	4	10	7
Receivables	0	0	0	0
Inventory	1	1	1	1
Other	—	—	—	—
	8	5	12	9

	2023	2024	2025	Q'26
Payables	1	1	1	0
ST’ Debt	—	—	—	—
Other	—	—	—	—
	2	2	2	2

Compound Annual Growth %

	10y	5y	3y
Sales	33.90%	(0.03%)	(1.39%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	33.86%	12.20%	(8.10%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	3	3	—	—	—
’25	3	3	3	3	11
’24	3	2	3	2	10
’23	3	2	2	2	10
’22	4	3	3	2	12
’21	2	3	2	2	10
’20	4	2	3	3	11

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(2)	0	—	—	—
’25	(2)	(1)	(1)	(2)	(5)
’24	(1)	(2)	(1)	(1)	(4)
’23	(1)	(2)	0	(1)	(4)
’22	0	(1)	(1)	(2)	(4)
’21	(1)	(1)	(2)	(3)	(6)
’20	1	0	(1)	0	0

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(2)	0	—	—	—
’25	(8)	(9)	(1)	(2)	(6)
’24	(1)	(2)	(1)	(1)	(6)
’23	(2)	(2)	(1)	(1)	(6)
’22	0	(1)	(2)	(2)	(5)
’22	—	—	—	—	(4)
’21	(1)	(1)	(2)	(3)	(6)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.68)	(1.81)	—	—	—
’25	(92.31)	(2.80)	(2.21)	(1.96)	(13.06)
’24	(16.35k)	(18.46k)	(3.85k)	26.44k	(11.27k)
’23	(36.92k)	(35.19k)	(21.15k)	(133.27k)	(206.76k)
’22	(53.85k)	(50.00k)	(88.46k)	(100.00k)	(292.31k)
’21	(461.54k)	(76.92k)	(0.11)	(0.77)	(857.69k)
’20	0.01	(0.02)	(0.31)	(269.23k)	(423.08k)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	8,250,000.00	3,787,500.00	1,987,500.00	948,750.00	798,750.00	881,250.00	138,750.00	15,937.50	1,057.50	0.63	Analyst estimates 2026–2028 Powerpack
	High	50,625,000.00	32,212,500.00	14,925,000.00	5,250,000.00	7,950,000.00	12,900,000.00	1,676,250.00	198,750.00	24,187.50	1,314.75
People
People	Employees	41	55	34	30	19	19	27	27	32	35
	Revenue/emp, $m	0.19	0.29	0.50	0.57	0.60	0.53	0.44	0.37	0.31	0.33
Income, $m
Income, $m	Revenue	8	16	17	17	11	10	12	10	10	11
	Gross margin, %	42.68	68.43	71.93	74.51	67.08	57.72	60.68	67.07	66.81	66.79
	EBT	(13)	(8)	(1)	(3)	(3)	(12)	(7)	(15)	(9)	(7)
	EBT margin, %	(162.31)	(52.29)	(7.56)	(15.76)	(24.82)	(114.78)	(56.95)	(149.66)	(90.83)	(65.23)
	Net income	(13)	(8)	(7)	(12)	(3)	(12)	(7)	(15)	(9)	(7)
	Depreciation	2	4	1	2	1	6	1	9	2	2
Per share, $
Per share, $	Revenue	1.25	1.25	0.70	0.60	3.51	1.59	0.00	99,296.00	12,377.50	19.21
	Earnings	(2.07)	(2,070,519.00)	(1,115,385.00)	(1,615,384.00)	(423,076.90)	(857,692.30)	(292,307.70)	(206,764.40)	(11,269.23)	(13.06)
	Cash flow	(0.15)	(0.11)	0.00	0.08	(0.10)	(0.94)	0.00	(43,155.00)	(5,318.50)	(8.51)
	Capex	(0.01)	0.00	0.00	0.00	0.00	0.00	0.00	(13,734.00)	(1,825.75)	(2.39)
	Free cash flow	(0.16)	(0.11)	0.00	0.08	(0.10)	(0.94)	0.00	(56,889.00)	(7,144.25)	(10.90)
	Book value	0.46	1.49	0.60	0.23	2.81	4.22	0.00	131,052.00	12,981.50	27.37
	Shares, m	6	13	25	29	3	6	0	0	0	1
Valuation, ×
Valuation, ×	P/E	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	8,316,930.36	10,930,820.73	3,659,244.93	2,827,762.85	1,708,847.48	722,235.38	0.00	0.20	0.09	0.04
	P/B	0.00	9,166,880.12	4,250,115.36	7,217,099.68	2,134,902.61	277,657.74	0.00	0.16	0.09	0.03
	EV/Sales	8,316,931.76	10,930,821.14	3,659,245.70	2,827,763.44	1,708,847.98	722,234.57	(0.25)	(0.03)	0.12	(0.44)
	EV/FCF	(62,113,245.38)	(123,652,698.29)	(590,878,424.87)	21,865,247.29	(58,058,211.72)	(1,219,042.23)	0.60	0.06	(0.20)	0.25
Cash, $m
Cash, $m	Operating cash flow	(1)	(1)	0	2	0	(6)	(4)	(4)	(4)	(5)
	Capex	0	0	0	0	—	—	(1)	(1)	(1)	(1)
	Free cash flow	(1)	(1)	0	2	0	(6)	(5)	(6)	(6)	(6)
Balance, $m
Balance, $m	Working capital	(2)	1	(2)	(2)	(1)	13	7	6	3	10
	Total debt	14	12	15	12	10	0	0	—	—	—
	Net debt	11	7	13	10	6	(12)	(7)	(6)	(4)	(10)
	Shareholders’ equity	3	19	15	7	9	27	21	13	10	16
Returns, %
Returns, %	ROA	(68.36)	(21.51)	(16.66)	(37.84)	(14.32)	(49.23)	(26.01)	(73.99)	(59.57)	(44.99)
	ROIC	(30.59)	(5.20)	1.32	9.60	(2.46)	(32.91)	(30.96)	(142.84)	(72.88)	(72.89)
	ROE	4,830.20	(101.77)	(42.46)	(111.32)	(46.92)	(79.76)	(31.18)	(94.93)	(83.14)	(60.78)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
HLTHQ Cue Health Inc.	$6.9M	— (loss-making)	— (loss-making)	−87.19% (below 0%: shrinking)	n/m	+50.55% (above 0%: growing)	(90.14%)	(792.13%)	Compare
ZCMD Zhongchao Inc.	$6.2M	— (loss-making)	—	+20.44% (above 0%: growing)	−550.00% (below 0%: shrinking)	+191.85% (above 0%: growing)	41.67%	0.00%	Compare
ACON Aclarion, Inc.	$5.6M	— (loss-making)	— (loss-making)	+30.57% (above 0%: growing)	n/m	−41.41% (below 0%: shrinking)	32.94%	(11,506.75%)	Compare
VSEED VSee Health, Inc.	$2.8M	— (loss-making)	— (loss-making)	+48.02% (above 0%: growing)	n/m	−257.62% (below 0%: shrinking)	13.20%	(172.69%)	Compare
LGMK LogicMark, Inc.	$1.7M	— (loss-making)	— (loss-making)	+17.39% (above 0%: growing)	n/m	+96.41% (above 0%: growing)	70.71%	(47.60%)
MSPR MSP Recovery, Inc.	$1.5M	— (loss-making)	—	−94.60% (below 0%: shrinking)	n/m	+60.88% (above 0%: growing)	(26.77%)	(62,501.52%)	Compare
MNDR Mobile-health Network Solutions	$1.3M	—	—	—	—	—	—	—	Compare
WORX SCWorx Corp.	$1.1M	0.1×	— (loss-making)	+3.43% (above 0%: growing)	n/m	+87.99% (above 0%: growing)	46.80%	(17.14%)	Compare
ICCT iCoreConnect Inc.	$800.0K	— (loss-making)	—	−12.37% (below 0%: shrinking)	n/m	+91.63% (above 0%: growing)	74.39%	(129.31%)	Compare
Median of peers	$2.2M	—	—	+3.43%	—	+60.88%	32.94%	(172.69%)

All 51 Health Information Services stocks →

LogicMark, Inc. (LGMK) key facts

Strength: LogicMark, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, up 15.4% from fiscal 2024.
LogicMark, Inc. (LGMK) is a Health Information Services company in the Healthcare sector.
As of October 14, 2026, LGMK traded at $1.30, a market capitalization of $1.7 million.
Return on equity was −60.8% and debt-to-equity 0.00.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −8.13 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.